Susquehanna International Group, LLP Vaxart, Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.58 - $0.99 $46,284 - $79,002	79,800 Added 558.04%	94,100 $79,000
Q2 2024 Aug 15, 2024	BUY	$0.53 - $1.3 $7,579 - $18,590	14,300 New	14,300 $9,000
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $38,775 - $115,808	-51,700 Reduced 44.49%	64,500 $61,000
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $351,329 - $756,450	-168,100 Reduced 59.13%	116,200 $253,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $78,570 - $153,648	29,100 Added 11.4%	284,300 $995,000
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $651,222 - $1.01 Million	-151,800 Reduced 37.3%	255,200 $1.29 Million
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $1.04 Million - $1.44 Million	-180,700 Reduced 30.75%	407,000 $2.55 Million
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $546,273 - $802,620	-81,900 Reduced 12.23%	587,700 $4.67 Million
Q2 2021 Aug 11, 2021	SELL	$5.06 - $10.78 $604,670 - $1.29 Million	-119,500 Reduced 15.14%	669,600 $5.02 Million
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $1.46 Million - $6.04 Million	-259,000 Reduced 24.71%	789,100 $4.77 Million
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $1.28 Million - $2.91 Million	365,100 Added 53.46%	1,048,100 $5.99 Million
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $3.26 Million - $11.6 Million	683,000 New	683,000 $4.54 Million

109

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.